『Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD』のカバーアート

Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
まだレビューはありません